Home / Compounds / Blue Lotus (Nymphaea caerulea) / District of Columbia

Is Blue Lotus (Nymphaea caerulea) Legal in District of Columbia? (2026)

Legal

As of October 22, 2026, Blue Lotus (Nymphaea caerulea) is legal to sell at retail in District of Columbia. Not scheduled; no named ban or consumption restriction. Controlling source: D.C. Code Sec. 48-902.04(3) (Schedule I).

Verified October 22, 2026 (hash check) · confidence: confirmed
Rule type
permanent
Tier
unscheduled

Controlling language, verbatim

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers... [closed list A-AA+; no Nymphaea, nuciferine, or apomorphine]

Source of excerpt

Citations

  1. D.C. Code Sec. 48-902.04(3) (Schedule I) (D.C. Law Library, 2026-06-25) PRIMARYOFFICIAL

Where Blue Lotus (Nymphaea caerulea) stands across the country

LegalRestrictedGray areaIllegalNot yet verified

Among District of Columbia's 2 neighbors, Maryland and Virginia are legal, the same posture as District of Columbia.

Open the interactive map · Every compound in District of Columbia

Federal posture

Not federally scheduled. Unscheduled federally; FDA has not approved it for human consumption Federal detail

Verbatim law on file for District of Columbia

2 instruments on file for this compound's framework in District of Columbia; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

D.C. Code § 48-902.04(3) (Schedule I hallucinogens — enumerated, 4-HO-MET absent); § 48-902.14 (controlled substances analogue)OFFICIAL
Instrument
statute
Source
https://code.dccouncil.gov/us/dc/council/code/sections/48-902.04
Retrieved
2026-06-19
Fingerprint
2a848ce471c86d2c
**§ 48-902.04(3) (hallucinogen chapeau)** — "(3) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:"
— D.C. Code § 48-902.04(3), https://code.dccouncil.gov/us/dc/council/code/sections/48-902.04 (OFFICIAL — DC Council). Psilocyn (3)(S) and even 4-AcO-DMT are listed; 4-HO-MET is not.
**§ 48-902.14 (controlled substances analogue)** — "(a) A controlled substances analogue shall, to the extent intended for human consumption, be treated for the purposes of any District of Columbia law as a controlled substance in Schedule I. (b) … the term 'controlled analogue' means: (1) a substance with a chemical structure that is substantially similar to the chemical structure of a controlled substance in Schedule I or II; (2) A substance that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than [that] of a controlled substance in Schedule I or II; or (3) A substance that … is represented to have or is intended to have [such effect] …"
— D.C. Code § 48-902.14, https://code.dccouncil.gov/us/dc/council/code/sections/48-902.14 (OFFICIAL — DC Council).
D.C. Code Sec. 48-902.14 · Treatment of controlled substance analoguesOFFICIAL
Instrument
Treatment of controlled substance analogues
Source
https://code.dccouncil.gov/us/dc/council/code/sections/48-902.14
Retrieved
2026-07-20
Fingerprint
8b8d79b80f81cf85
(a) A controlled substances analogue shall, to the extent intended for human consumption, be treated for the purposes of any District of Columbia law as a controlled substance in Schedule I. (b) Except as provided in subsection (c) of this section, the term controlled analogue means: (1) a substance with a chemical structure that is substantially similar to the chemical structure of a controlled substance in Schedule I or II; (2) A substance that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central system of a controlled substance in Schedule I or II; or (3) A substance that, with respect to a particular person, is represented to have or is intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II. (c) Such term does not include: (1) A controlled substance; (2) Any substance for which there is an approved new drug application; (3) With respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under Section 505 of the Federal Food, Drug, and Cosmetic Act, approved June 25, 1938 (52 Stat. 1052, 21 U.S.C. Section 355) to the extent conduct with respect to such substance is pursuant to such exemption; or (4) Any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance.

Related

Blue Lotus (Nymphaea caerulea) in neighboring states

Blue Lotus (Nymphaea caerulea) in other states

Same framework in District of Columbia

Other compounds in District of Columbia

Cite this page

Compound Analytics. "Is Blue Lotus (Nymphaea caerulea) Legal in District of Columbia? (2026)." Compound Laws, https://compoundlaws.com/compounds/blue-lotus/district-of-columbia/. Accessed October 25, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap